41 results on '"Nicoletti, Carmine"'
Search Results
2. A KO mouse model for the lncRNA Lhx1os produces motor neuron alterations and locomotor impairment
- Author
-
Pellegrini, Flaminia, Padovano, Vittorio, Biscarini, Silvia, Santini, Tiziana, Setti, Adriano, Galfrè, Silvia Giulia, Silenzi, Valentina, Vitiello, Erika, Mariani, Davide, Nicoletti, Carmine, Torromino, Giulia, De Leonibus, Elvira, Martone, Julie, and Bozzoni, Irene
- Published
- 2023
- Full Text
- View/download PDF
3. Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential
- Author
-
Cardinale, Vincenzo, Carpino, Guido, Overi, Diletta, Safarikia, Samira, Zhang, Wencheng, Kanke, Matt, Franchitto, Antonio, Costantini, Daniele, Riccioni, Olga, Nevi, Lorenzo, Chiappetta, Michele, Onori, Paolo, Franchitto, Matteo, Bini, Simone, Hung, Yu-Han, Lai, Quirino, Zizzari, Ilaria, Nuti, Marianna, Nicoletti, Carmine, Checquolo, Saula, Di Magno, Laura, Giuli, Maria Valeria, Rossi, Massimo, Sethupathy, Praveen, Reid, Lola M., Alvaro, Domenico, and Gaudio, Eugenio
- Published
- 2023
- Full Text
- View/download PDF
4. Muscle Expression of a Local Igf-1 Isoform Protects Motor Neurons in an ALS Mouse Model
- Author
-
Dobrowolny, Gabriella, Giacinti, Cristina, Pelosi, Laura, Nicoletti, Carmine, Winn, Nadine, Barberi, Laura, Molinaro, Mario, Rosenthal, Nadia, and Musarò, Antonio
- Published
- 2005
5. Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response
- Author
-
Giuli, Maria Valeria, Diluvio, Giulia, Giuliani, Eugenia, Franciosa, Giulia, Di Magno, Laura, Pignataro, Maria Gemma, Tottone, Luca, Nicoletti, Carmine, Besharat, Zein Mersini, Peruzzi, Giovanna, Pelullo, Maria, Palermo, Rocco, Canettieri, Gianluca, Talora, Claudio, d’Amati, Giulia, Bellavia, Diana, Screpanti, Isabella, and Checquolo, Saula
- Published
- 2020
- Full Text
- View/download PDF
6. Impact of diffused versus vasculature targeted DNA damage on the heart of mice depleted of telomeric factor Ft1.
- Author
-
La Torre, Mattia, Centofante, Eleonora, Nicoletti, Carmine, Burla, Romina, Giampietro, Alessandro, Cannistrà, Federica, Schirone, Leonardo, Valenti, Valentina, Sciarretta, Sebastiano, Musarò, Antonio, and Saggio, Isabella
- Subjects
HEART ,DNA damage ,HEART failure ,LEFT heart ventricle ,BLOOD vessels ,HEART abnormalities - Abstract
DNA damage is emerging as a driver of heart disease, although the cascade of events, its timing, and the cell types involved are yet to be fully clarified. In this context, the implication of cardiomyocytes has been highlighted, while that of vasculature smooth muscle cells has been implicated but not explored exhaustively. In our previous work we characterized a factor called Ft1 in mice and AKTIP in humans whose depletion generates telomere instability and DNA damage. Herein, we explored the effect of the reduction of Ft1 on the heart with the goal of comparatively defining the impact of DNA damage targeted to vasculature smooth muscle cells to that of diffuse damage. Using two newly generated mouse models, Ft1 constitutively knocked out (Ft1ko) mice, and mice in which we targeted the Ft1 depletion to the smooth muscle cells (Ft1sm22ko), it is shown that both genetic models display cardiac defects but with differences. Both Ft1ko and Ft1sm22ko mice display hypertrophy, fibrosis, and functional heart defects. Interestingly, Ft1sm22ko mice have early milder pathological traits that become manifest with age. Significantly, the defects of Ft1ko mice, including the alteration of the left ventricle and functional heart defects, are rescued by depletion of the DNA damage sensor p53. These results point to Ft1 deficiency as a driver of cardiac disease and show that Ft1 deficiency targeted to vasculature smooth muscle cells generates a pre‐pathological profile exacerbated by age. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice
- Author
-
Chiappalupi, Sara, Luca, Giovanni, Mancuso, Francesca, Madaro, Luca, Fallarino, Francesca, Nicoletti, Carmine, Calvitti, Mario, Arato, Iva, Falabella, Giulia, Salvadori, Laura, Di Meo, Antonio, Bufalari, Antonello, Giovagnoli, Stefano, Calafiore, Riccardo, Donato, Rosario, and Sorci, Guglielmo
- Published
- 2016
- Full Text
- View/download PDF
8. The long noncoding RNA Charme supervises cardiomyocyte maturation by controlling cell differentiation programs in the developing heart.
- Author
-
Taliani, Valeria, Buonaiuto, Giulia, Desideri, Fabio, Setti, Adriano, Santini, Tiziana, Galfrè, Silvia, Schirone, Leonardo, Mariani, Davide, Frati, Giacomo, Valenti, Valentina, Sciarretta, Sebastiano, Perlas, Emerald, Nicoletti, Carmine, Musarò, Antonio, and Ballarino, Monica
- Published
- 2023
- Full Text
- View/download PDF
9. Body-Wide Gene Therapy of Duchenne Muscular Dystrophy in the mdx Mouse Model
- Author
-
Denti, Michela Alessandra, Rosa, Alessandro, D'Antona, Giuseppe, Sthandier, Olga, De Angelis, Fernanda Gabriella, Nicoletti, Carmine, Allocca, Mariacarmela, Pansarasa, Orietta, Parente, Valeria, Musarò, Antonio, Auricchio, Alberto, Bottinelli, Roberto, and Bozzoni, Irene
- Published
- 2006
- Full Text
- View/download PDF
10. Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice
- Author
-
Pelosi, Laura, Berardinelli, Maria Grazia, Forcina, Laura, Spelta, Elisa, Rizzuto, Emanuele, Nicoletti, Carmine, Camilli, Carlotta, Testa, Erika, Catizone, Angela, De Benedetti, Fabrizio, and Musarò, Antonio
- Published
- 2015
- Full Text
- View/download PDF
11. MicroRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS Pathway
- Author
-
Cacchiarelli, Davide, Martone, Julie, Girardi, Erika, Cesana, Marcella, Incitti, Tania, Morlando, Mariangela, Nicoletti, Carmine, Santini, Tiziana, Sthandier, Olga, Barberi, Laura, Auricchio, Alberto, Musarò, Antonio, and Bozzoni, Irene
- Published
- 2010
- Full Text
- View/download PDF
12. Skeletal Muscle Is a Primary Target of SOD1 G93A-Mediated Toxicity
- Author
-
Dobrowolny, Gabriella, Aucello, Michela, Rizzuto, Emanuele, Beccafico, Sara, Mammucari, Cristina, Bonconpagni, Simona, Belia, Silvia, Wannenes, Francesca, Nicoletti, Carmine, Del Prete, Zaccaria, Rosenthal, Nadia, Molinaro, Mario, Protasi, Feliciano, Fanò, Giorgio, Sandri, Marco, and Musarò, Antonio
- Published
- 2008
- Full Text
- View/download PDF
13. Muscle expression of a local lgf-1 isoform protects motor neurons in an ALS mouse model
- Author
-
Dobrowolny, Gabriella, Giacinti, Cristina, Pelosi, Laura, Nicoletti, Carmine, Winn, Nadine, Barberi, Laura, Molinaro, Mario, Rosenthal, Nadia, and Musaro, Antonio
- Subjects
Amyotrophic lateral sclerosis -- Research ,Amyotrophic lateral sclerosis -- Genetic aspects ,Cytology -- Research ,Biological sciences - Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by a selective degeneration of motor neurons, atrophy, and paralysis of skeletal muscle. Although a significant proportion of familial ALS results from a toxic gain of function associated with dominant SOD1 mutations, the etiology of the disease and its specific cellular origins have remained difficult to define. Here, we show that muscle-restricted expression of a localized insulin-like growth factor (Igf)-1 isoform maintained muscle integrity and enhanced satellite cell activity in [SOD1.sup.G93A] transgenic mice, inducing calcineurin-mediated regenerative pathways. Muscle-specific expression of local Igf-1 (mIgf-1) isoform also stabilized neuromuscular junctions, reduced inflammation in the spinal cord, and enhanced motor neuronal survival in [SOD1.sup.G93A] mice, delaying the onset and progression of the disease. These studies establish skeletal muscle as a primary target for the dominant action of inherited SOD1 mutation and suggest that muscle fibers provide appropriate factors, such as mIgf-1, for neuron survival.
- Published
- 2005
14. Opsonin-Deficient Nucleoproteic Corona Endows UnPEGylated Liposomes with Stealth Properties In Vivo.
- Author
-
Giulimondi, Francesca, Vulpis, Elisabetta, Digiacomo, Luca, Giuli, Maria Valeria, Mancusi, Angelica, Capriotti, Anna Laura, Laganà, Aldo, Cerrato, Andrea, Zenezini Chiozzi, Riccardo, Nicoletti, Carmine, Amenitsch, Heinz, Cardarelli, Francesco, Masuelli, Laura, Bei, Roberto, Screpanti, Isabella, Pozzi, Daniela, Zingoni, Alessandra, Checquolo, Saula, and Caracciolo, Giulio
- Published
- 2022
- Full Text
- View/download PDF
15. Effect of direct renin inhibition on vascular function after long-term treatment with aliskiren in hypertensive and diabetic patients.
- Author
-
Savoia, Carmine, De Ciuceis, Carolina, Paini, Anna, Carletti, Raffaella, Arrabito, Emanuele, Nicoletti, Carmine, Mercantini, Paolo, Di Gioia, Cira, Battistoni, Allegra, Ucci, Sarassunta, Filippini, Antonio, Rosei, Enrico Agabiti, Volpe, Massimo, Muiesan, Maria L., Rizzoni, Damiano, Salvetti, Massimo, and Agabiti Rosei, Enrico
- Published
- 2021
- Full Text
- View/download PDF
16. Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension.
- Author
-
Savoia, Carmine, Arrabito, Emanuele, Parente, Rosa, Nicoletti, Carmine, Madaro, Luca, Battistoni, Allegra, Filippini, Antonio, Steckelings, Ulrike M., Touyz, Rhian M., and Volpe, Massimo
- Abstract
Angiotensin (1-7) production increases during AT1R (angiotensin type-1 receptor) blockade. The contribution of Ang (1-7) (angiotensin [1-7]) and its receptor (MasR) to the favorable effect of angiotensin receptor blockers on remodeling and function of resistance arteries remains unclear. We sought to determine whether MasR contributes to the improvement of vascular structure and function during chronic AT1R blockade. Spontaneously hypertensive rats were treated with Ang (1-7) or olmesartan ± MasR antagonist A-779, or vehicle, for 14 days. Blood pressure was measured by tail cuff methodology. Mesenteric arteries were dissected and mounted on a pressurized micromyograph to evaluate media-to-lumen ratio (M/L) and endothelial function. Expression of MasR and eNOS (endothelial nitric oxide synthase) was evaluated by immunoblotting, plasma nitrate by colorimetric assay, and reactive oxygen species production by dihydroethidium staining. Independently of blood pressure, olmesartan significantly reduced M/L and improved NO bioavailability, A-779 prevented these effects. Likewise, Ang (1-7) significantly reduced M/L and NO bioavailability. MasR expression was significantly increased by Ang (1-7) as well as by olmesartan, and it was blunted in the presence of A-779. Both Ang (1-7) and olmesartan increased eNOS expression and plasma nitrite which were reduced by A-779. Superoxide generation was attenuated by olmesartan and Ang (1-7) and was blunted in the presence of A-779. These MasR-mediated actions were independent of AT2R activation since olmesartan and Ang (1-7) increased MasR expression and reduced M/L in Ang II (angiotensin II)-infused AT2R knockout mice, independently of blood pressure control. A-779 prevented these effects. Hence, MasR activation may contribute to the favorable effects of AT1R antagonism on NO bioavailability and microvascular remodeling, independently of AT2R activation and blood pressure control. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
17. Effects of IGF‐1 isoforms on muscle growth and sarcopenia.
- Author
-
Ascenzi, Francesca, Barberi, Laura, Dobrowolny, Gabriella, Villa Nova Bacurau, Aline, Nicoletti, Carmine, Rizzuto, Emanuele, Rosenthal, Nadia, Scicchitano, Bianca Maria, and Musarò, Antonio
- Subjects
MUSCLE growth ,SKELETAL muscle ,MUSCLE mass ,MUSCLE weakness ,TRANSGENIC mice ,MYONEURAL junction - Abstract
The decline in skeletal muscle mass and strength occurring in aging, referred as sarcopenia, is the result of many factors including an imbalance between protein synthesis and degradation, changes in metabolic/hormonal status, and in circulating levels of inflammatory mediators. Thus, factors that increase muscle mass and promote anabolic pathways might be of therapeutic benefit to counteract sarcopenia. Among these, the insulin‐like growth factor‐1 (IGF‐1) has been implicated in many anabolic pathways in skeletal muscle. IGF‐1 exists in different isoforms that might exert different role in skeletal muscle. Here we study the effects of two full propeptides IGF‐1Ea and IGF‐1Eb in skeletal muscle, with the aim to define whether and through which mechanisms their overexpression impacts muscle aging. We report that only IGF‐1Ea expression promotes a pronounced hypertrophic phenotype in young mice, which is maintained in aged mice. Nevertheless, examination of aged transgenic mice revealed that the local expression of either IGF‐1Ea or IGF‐1Eb transgenes was protective against age‐related loss of muscle mass and force. At molecular level, both isoforms activate the autophagy/lysosome system, normally altered during aging, and increase PGC1‐α expression, modulating mitochondrial function, ROS detoxification, and the basal inflammatory state occurring at old age. Moreover, morphological integrity of neuromuscular junctions was maintained and preserved in both MLC/IGF‐1Ea and MLC/IGF‐1Eb mice during aging. These data suggest that IGF‐1 is a promising therapeutic agent in staving off advancing muscle weakness. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
18. Deficiency in the nuclear long noncoding RNA Charme causes myogenic defects and heart remodeling in mice.
- Author
-
Ballarino, Monica, Cipriano, Andrea, Tita, Rossella, Santini, Tiziana, Desideri, Fabio, Morlando, Mariangela, Colantoni, Alessio, Carrieri, Claudia, Nicoletti, Carmine, Musarò, Antonio, Carroll, Dònal O’, and Bozzoni, Irene
- Subjects
MYOGENESIS ,EMBRYOLOGY ,PROGENITOR cells ,MYOBLASTS ,RNA - Abstract
Abstract: Myogenesis is a highly regulated process that involves the conversion of progenitor cells into multinucleated myofibers. Besides proteins and miRNAs, long noncoding RNAs (lncRNAs) have been shown to participate in myogenic regulatory circuitries. Here, we characterize a murine chromatin‐associated muscle‐specific lncRNA, Charme, which contributes to the robustness of the myogenic program in vitro and in vivo. In myocytes, Charme depletion triggers the disassembly of a specific chromosomal domain and the downregulation of myogenic genes contained therein. Notably, several Charme‐sensitive genes are associated with human cardiomyopathies and Charme depletion in mice results in a peculiar cardiac remodeling phenotype with changes in size, structure, and shape of the heart. Moreover, the existence of an orthologous transcript in human, regulating the same subset of target genes, suggests an important and evolutionarily conserved function for Charme. Altogether, these data describe a new example of a chromatin‐associated lncRNA regulating the robustness of skeletal and cardiac myogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
19. Muscle Expression of SOD1G93A Triggers the Dismantlement of Neuromuscular Junction via PKC-Theta.
- Author
-
Dobrowolny, Gabriella, Martini, Martina, Scicchitano, Bianca Maria, Romanello, Vanina, Boncompagni, Simona, Nicoletti, Carmine, Pietrangelo, Laura, De Panfilis, Simone, Catizone, Angela, Bouchè, Marina, Sandri, Marco, Rudolf, Rüdiger, Protasi, Feliciano, and Musarò, Antonio
- Published
- 2018
- Full Text
- View/download PDF
20. Increased Circulating Levels of Interleukin-6 Induce Perturbation in Redox-Regulated Signaling Cascades in Muscle of Dystrophic Mice.
- Author
-
Pelosi, Laura, Forcina, Laura, Nicoletti, Carmine, Scicchitano, Bianca Maria, and Musarò, Antonio
- Published
- 2017
- Full Text
- View/download PDF
21. Skeletal muscle myopenia in mice model of bile duct ligation and carbon tetrachloride-induced liver cirrhosis.
- Author
-
Giusto, Michela, Barberi, Laura, Di Sario, Francesca, Rizzuto, Emanuele, Nicoletti, Carmine, Ascenzi, Francesca, Renzi, Anastasia, Caporaso, Nicola, D'Argenio, Giuseppe, Gaudio, Eugenio, Musarò, Antonio, and Merli, Manuela
- Subjects
SKELETAL muscle ,CARBON tetrachloride ,CIRRHOSIS of the liver ,MYOSTATIN ,LABORATORY mice ,DISEASES - Abstract
Skeletal muscle myopathy is universal in cirrhotic patients, however, little is known about the main mechanisms involved. The study aims to investigate skeletal muscle morphological, histological, and functional modifications in experimental models of cirrhosis and the principal molecular pathways responsible for skeletal muscle myopathy. Cirrhosis was induced by bile duct ligation (BDL) and carbon tetrachloride (CCl4) administration in mice. Control animals (CTR) underwent bile duct exposure or vehicle administration only. At sacrifice, peripheral muscles were dissected and weighed. Contractile properties of extensor digitorum longus (EDL) were studied in vitro. Muscle samples were used for histological and molecular analysis. Quadriceps muscle histology revealed a significant reduction in cross-sectional area of muscle and muscle fibers in cirrhotic mice with respect to CTR. Kinetic properties of EDL in both BDL and CCl4 were reduced with respect to CTR; BDL mice also showed a reduction in muscle force and a decrease in the resistance to fatigue. Increase in myostatin expression associated with a decrease in AKT-mTOR expressions was observed in BDL mice, together with an increase in LC3 protein levels. Upregulation of the proinflammatory citochines TNF-a and IL6 and an increased expression of NF-κB and MuRF-1 were observed in CCl4 mice. In conclusion, skeletal muscle myopenia was present in experimental models of BDL and CCl4-induced cirrhosis. Moreover, reduction in protein synthesis and activation of protein degradation were the main mechanisms responsible for myopenia in BDL mice, while activation of ubiquitin-pathway through inflammatory cytokines seems to be the main potential mechanism involved in CCl4 mice. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
22. Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy.
- Author
-
Baruffaldi, Fiorenza, Montarras, Didier, Basile, Valentina, De Feo, Luca, Badodi, Sara, Ganassi, Massimo, Battini, Renata, Nicoletti, Carmine, Imbriano, Carol, Musarò, Antonio, and Molinari, Susanna
- Abstract
A bstract The transcription factor MEF2C (Myocyte Enhancer Factor 2C) plays an established role in the early steps of myogenic differentiation. However, the involvement of MEF2C in adult myogenesis and in muscle regeneration has not yet been systematically investigated. Alternative splicing of mammalian MEF2C transcripts gives rise to two mutually exclusive protein variants: MEF2Cα2 which exerts a positive control of myogenic differentiation, and MEF2Cα1, in which the α1 domain acts as trans-repressor of the MEF2C pro-differentiation activity itself. However, MEF2Cα1 variants are persistently expressed in differentiating cultured myocytes, suggesting a role in adult myogenesis. We found that overexpression of both MEF2Cα1/α2 proteins in a mouse model of muscle injury promotes muscle regeneration and hypertrophy, with each isoform promoting different stages of myogenesis. Besides the ability of MEF2Cα2 to increase differentiation, we found that overexpressed MEF2Cα1 enhances both proliferation and differentiation of primary myoblasts, and activates the AKT/mTOR/S6K anabolic signaling pathway in newly formed myofibers. The multiple activities of MEF2Cα1 are modulated by phosphorylation of Ser98 and Ser110, two amino acid residues located in the α1 domain of MEF2Cα1. These specific phosphorylations allow the interaction of MEF2Cα1 with the peptidyl-prolyl isomerase PIN1, a regulator of MEF2C functions. Overall, in this study we established a novel regulatory mechanism in which the expression and the phosphorylation of MEF2Cα1 are critically required to sustain the adult myogenesis. The described molecular mechanism will represent a new potential target for the development of therapeutical strategies to treat muscle-wasting diseases. S tem C ells 2017;35:725-738 [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
23. Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential.
- Author
-
Oltolina, Francesca, Zamperone, Andrea, Colangelo, Donato, Gregoletto, Luca, Reano, Simone, Pietronave, Stefano, Merlin, Simone, Talmon, Maria, Novelli, Eugenio, Diena, Marco, Nicoletti, Carmine, Musarò, Antonio, Filigheddu, Nicoletta, Follenzi, Antonia, and Prat, Maria
- Subjects
MYOCARDIUM physiology ,STEM cell treatment ,CELL aggregation ,EXTRACELLULAR matrix ,METHYLCELLULOSE ,IMMUNOFLUORESCENCE - Abstract
A major obstacle to an effective myocardium stem cell therapy has always been the delivery and survival of implanted stem cells in the heart. Better engraftment can be achieved if cells are administered as cell aggregates, which maintain their extra-cellular matrix (ECM). We have generated spheroid aggregates in less than 24 h by seeding human cardiac progenitor cells (hCPCs) onto methylcellulose hydrogel-coated microwells. Cells within spheroids maintained the expression of stemness/mesenchymal and ECM markers, growth factors and their cognate receptors, cardiac commitment factors, and metalloproteases, as detected by immunofluorescence, q-RT-PCR and immunoarray, and expressed a higher, but regulated, telomerase activity. Compared to cells in monolayers, 3D spheroids secreted also bFGF and showed MMP2 activity. When spheroids were seeded on culture plates, the cells quickly migrated, displaying an increased wound healing ability with or without pharmacological modulation, and reached confluence at a higher rate than cells from conventional monolayers. When spheroids were injected in the heart wall of healthy mice, some cells migrated from the spheroids, engrafted, and remained detectable for at least 1 week after transplantation, while, when the same amount of cells was injected as suspension, no cells were detectable three days after injection. Cells from spheroids displayed the same engraftment capability when they were injected in cardiotoxin-injured myocardium. Our study shows that spherical in vivo ready-to-implant scaffold-less aggregates of hCPCs able to engraft also in the hostile environment of an injured myocardium can be produced with an economic, easy and fast protocol. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
24. Proliferation of Multiple Cell Types in the Skeletal Muscle Tissue Elicited by Acute p21 Suppression.
- Author
-
Biferi, Maria Grazia, Nicoletti, Carmine, Falcone, Germana, Puggioni, Eleonora M R, Passaro, Nunzia, Mazzola, Alessia, Pajalunga, Deborah, Zaccagnini, Germana, Rizzuto, Emanuele, Auricchio, Alberto, Zentilin, Lorena, De Luca, Gabriele, Giacca, Mauro, Martelli, Fabio, Musio, Antonio, Musarò, Antonio, and Crescenzi, Marco
- Subjects
- *
STRIATED muscle , *SKELETAL muscle , *MEDICINE , *DNA , *ADENO-associated virus - Abstract
Although in the last decades the molecular underpinnings of the cell cycle have been unraveled, the acquired knowledge has been rarely translated into practical applications. Here, we investigate the feasibility and safety of triggering proliferation in vivo by temporary suppression of the cyclin-dependent kinase inhibitor, p21. Adeno-associated virus (AAV)-mediated, acute knockdown of p21 in intact skeletal muscles elicited proliferation of multiple, otherwise quiescent cell types, notably including satellite cells. Compared with controls, p21-suppressed muscles exhibited a striking two- to threefold expansion in cellularity and increased fiber numbers by 10 days post-transduction, with no detectable inflammation. These changes partially persisted for at least 60 days, indicating that the muscles had undergone lasting modifications. Furthermore, morphological hyperplasia was accompanied by 20% increases in maximum strength and resistance to fatigue. To assess the safety of transiently suppressing p21, cells subjected to p21 knockdown in vitro were analyzed for γ-H2AX accumulation, DNA fragmentation, cytogenetic abnormalities, ploidy, and mutations. Moreover, the differentiation competence of p21-suppressed myoblasts was investigated. These assays confirmed that transient suppression of p21 causes no genetic damage and does not impair differentiation. Our results establish the basis for further exploring the manipulation of the cell cycle as a strategy in regenerative medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
25. The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes.
- Author
-
SAVOIA, Carmine, ARRABITO, Emanuele, PARENTE, Rosa, SADA, Lidia, MADARO, Luca, NICOLETTI, Carmine, ZEZZA, Luigi, ALONZO, Alessandro, RUBATTU, Speranza, MICHELINI, Serena, MULLER, Dominik N., and VOLPE, Massimo
- Subjects
RENIN regulation ,ALISKIREN ,TISSUE remodeling ,TRANSGENIC mice ,ANGIOTENSINOGEN ,RAMIPRIL ,COMPARATIVE studies ,THERAPEUTICS - Abstract
In the present study, we tested the hypothesis that chronic treatment with the direct rennin inhibitor aliskiren improves the remodelling of resistance arteries in dTGR (double-transgenic rats). dTGR (5 weeks) were treated with aliskiren (3 mg/kg of body mass per day) or ramipril (1 mg/kg of body mass per day) for 14 days and compared with age-matched vehicle-treated dTGR. BP (blood pressure) was similarly reduced in both aliskiren-treated and ramipril-treated rats compared with control dTGR (167±1 and 169±2 mmHg compared with 197±4 mmHg respectively; P<0.05). The M/L (media-to-lumen) ratio assessed on pressurized preparations was equally reduced in aliskiren-treated and ramipril-treated rats compared with controls (6.3±0.5 and 6.4±0.2% compared with 9.8±0.4% respectively; P<0.05). Endothelium-dependent and -independent relaxations were similar among the groups. L-NAME (N(G)-nitro-L-arginine methyl ester) significantly reduced acetylcholine-induced dilation in drug-treated dTGR. This effect was significantly more prominent in aliskiren-treated rats. eNOS (endothelial NO synthase) expression showed a 2-fold increase only in aliskiren-treated dTGR as compared with controls (P<0.01) and ramipril-treated dTGR (P<0.05). Plasma nitrite, as an index of NO production, was significantly increased in dTGR treated with either aliskiren or ramipril compared with controls. Only aliskiren induced a 2-fold increase in plasma nitrite, which was significantly greater than that induced by ramipril (P<0.05). gp91(phox) expression and ROS (reactive oxygen species) production in aorta were significantly and similarly reduced by both drugs. In conclusion, equieffective hypotensive doses of aliskiren or ramipril reduced the M/L ratio of mesenteric arteries and improved oxidative stress in dTGR. However, only aliskiren increased further NO production in the vasculature. Hence, in dTGR, direct renin inhibition induces favourable effects similar to that induced by ACE (angiotensin-converting enzyme) inhibition in improving vascular remodelling through different mechanisms. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
26. PKC Theta Ablation Improves Healing in a Mouse Model of Muscular Dystrophy.
- Author
-
Madaro, Luca, Pelle, Andrea, Nicoletti, Carmine, Crupi, Annunziata, Marrocco, Valeria, Bossi, Gianluca, Soddu, Silvia, and Bouché, Marina
- Subjects
NEUROMUSCULAR diseases ,MUSCLE diseases ,NEUROLOGICAL disorders ,NEUROMUSCULAR system ,MUSCULAR dystrophy ,RODENTS ,GENETICS ,IMMUNE response - Abstract
Inflammation is a key pathological characteristic of dystrophic muscle lesion formation, limiting muscle regeneration and resulting in fibrotic and fatty tissue replacement of muscle, which exacerbates the wasting process in dystrophic muscles. Limiting immune response is thus one of the therapeutic options to improve healing, as well as to improve the efficacy of gene- or cell-mediated strategies to restore dystrophin expression. Protein kinase θ h (PKCθ) is a member of the PKCs family highly expressed in both immune cells and skeletal muscle; given its crucial role in adaptive, but also innate, immunity, it is being proposed as a valuable pharmacological target for immune disorders. In our study we asked whether targeting PKCh could represent a valuable approach to efficiently prevent inflammatory response and disease progression in a mouse model of muscular dystrophy. We generated the bi-genetic mouse model mdx/θ
-/- , where PKCθ expression is lacking in mdx mice, the mouse model of Duchenne muscular dystrophy. We found that muscle wasting in mdx/θ-/- mice was greatly prevented, while muscle regeneration, maintenance and performance was significantly improved, as compared to mdx mice. This phenotype was associated to reduction in inflammatory infiltrate, pro-inflammatory gene expression and profibrotic markers activity, as compared to mdx mice. Moreover, BM transplantation experiments demonstrated that the phenotype observed was primarily dependent on lack of PKCθ expression in hematopoietic cells. These results demonstrate a hitherto unrecognized role of immune-cell intrinsic PKCθ activity in the development of DMD. Although the immune cell population(s) involved remain unidentified, our findings reveal that PKCθ can be proposed as a new pharmacological target to counteract the disease, as well as to improve the efficacy of gene- or cell- therapy approaches. [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
27. Human Cardiac Progenitor Cell Grafts as Unrestricted Source of Supernumerary Cardiac Cells in Healthy Murine Hearts.
- Author
-
Forte, Giancarlo, Pietronave, Stefano, Nardone, Giorgia, Zamperone, Andrea, Magnani, Eugenio, Pagliari, Stefania, Pagliari, Francesca, Giacinti, Cristina, Nicoletti, Carmine, Musaró, Antonio, Rinaldi, Mauro, Ribezzo, Marco, Comoglio, Chiara, Traversa, Enrico, Okano, Teruo, Minieri, Marilena, Prat, Maria, and Di Nardo, Paolo
- Subjects
TISSUE engineering ,CELLS ,STEM cells ,ANTIGENS ,HEART cells ,CELL suspensions - Abstract
Human heart harbors a population of resident progenitor cells that can be isolated by stem cell antigen-1 antibody and expanded in culture. These cells can differentiate into cardiomyocytes in vitro and contribute to cardiac regeneration in vivo. However, when directly injected as single cell suspension, less than 1%-5% survive and differentiate. Among the major causes of this failure are the distressing protocols used to culture in vitro and implant progenitor cells into damaged hearts. Human cardiac progenitors obtained from the auricles of patients were cultured as scaffoldless engineered tissues fabricated using temperature-responsive surfaces. In the engineered tissue, progenitor cells established proper three-dimensional intercellular relationships and were embedded in self-produced extracellular matrix preserving their phenotype and multipotency in the absence of significant apoptosis. After engineered tissues were leant on visceral pericardium, a number of cells migrated into the murine myocardium and in the vascular walls, where they integrated in the respective textures. The study demonstrates the suitability of such an approach to deliver stem cells to the myocardium. Interestingly, the successful delivery of cells in murine healthy hearts suggests that myocardium displays a continued cell cupidity that is strictly regulated by the limited release of progenitor cells by the adopted source. When an unregulated cell source is added to the system, cells are delivered to the myocardium. The exploitation of this novel concept may pave the way to the setup of new protocols in cardiac cell therapy. S TEM C ELLS 2011;29:2051-2061. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
28. Skeletal Muscle Is a Primary Target of SOD1G93A-Mediated Toxicity.
- Author
-
Dobrowolny, Gabriella, Aucello, Michela, Rizzuto, Emanuele, Beccafico, Sara, Mammucari, Cristina, Bonconpagni, Simona, Belia, Silvia, Wannenes, Francesca, Nicoletti, Carmine, Del Prete, Zaccaria, Rosenthal, Nadia, Molinaro, Mario, Protasi, Feliciano, Fanò, Giorgio, Sandri, Marco, and Musarò, Antonio
- Subjects
SUPEROXIDE dismutase ,ANTIOXIDANTS ,HOMEOSTASIS ,LABORATORY mice ,OXIDATIVE stress ,MUSCULAR atrophy ,GENE expression ,MUSCLE strength - Abstract
Summary: The antioxidant enzyme superoxide dismutase 1 (SOD1) is a critical player of the antioxidative defense whose activity is altered in several chronic diseases, including amyotrophic lateral sclerosis. However, how oxidative insult affects muscle homeostasis remains unclear. This study addresses the role of oxidative stress on muscle homeostasis and function by the generation of a transgenic mouse model expressing a mutant SOD1 gene (SOD1
G93A ) selectively in skeletal muscle. Transgenic mice developed progressive muscle atrophy, associated with a significant reduction in muscle strength, alterations in the contractile apparatus, and mitochondrial dysfunction. The analysis of molecular pathways associated with muscle atrophy revealed that accumulation of oxidative stress served as signaling molecules to initiate autophagy, one of the major intracellular degradation mechanisms. These data demonstrate that skeletal muscle is a primary target of SOD1G93A -mediated toxicity and disclose the molecular mechanism whereby oxidative stress triggers muscle atrophy. [Copyright &y& Elsevier]- Published
- 2008
- Full Text
- View/download PDF
29. Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines.
- Author
-
Pelosi, Laura, Giacinti, Cristina, Nardis, Chiara, Borsellino, Giovanna, Rizzuto, Emanuele, Nicoletti, Carmine, Wannenes, Francesca, Battistini, Luca, Rosenthal, Nadia, Molinaro, Mario, and Musarò, Antonio
- Subjects
SOMATOMEDIN ,MUSCLE regeneration ,CYTOKINES ,CHEMOKINES ,FIBROSIS ,WOUNDS & injuries - Abstract
Muscle regeneration following injury is characterized by myonecrosis accompanied by local inflammation, activation of satellite cells, and repair of injured fibers. The resolution of the inflammatory response is necessary to proceed toward muscle repair, since persistence of inflammation often renders the damaged muscle incapable of sustaining efficient muscle regeneration. Here, we show that local expression of a muscle-restricted insulin-like growth factor (IGF)-1 (mIGF-1) transgene accelerates the regenerative process of injured skeletal muscle, modulating the inflammatory response, and limiting fibrosis. At the molecular level, mIGF-1 expression significantly down-regulated proinflammatory cytokines, such as tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta, and modulated the expression of CC chemokines involved in the recruitment of monocytes/macrophages. Analysis of the underlying molecular mechanisms revealed that mIGF-1 expression modulated key players of inflammatory response, such as macrophage migration inhibitory factor (MIF), high mobility group protein-1 (HMGB1), and transcription NF-κB. The rapid restoration of injured mIGF-1 transgenic muscle was also associated with connective tissue remodeling and a rapid recovery of functional properties. By modulating the inflammatory response and reducing fibrosis, supplemental mIGF-1 creates a qualitatively different environment for sustaining more efficient muscle regeneration and repair. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
30. Circulating myomiRs in Muscle Denervation: From Surgical to ALS Pathological Condition.
- Author
-
Casola, Irene, Scicchitano, Bianca Maria, Lepore, Elisa, Mandillo, Silvia, Golini, Elisabetta, Nicoletti, Carmine, Barberi, Laura, Dobrowolny, Gabriella, and Musarò, Antonio
- Subjects
SKELETAL muscle ,AMYOTROPHIC lateral sclerosis ,DENERVATION ,MUSCULAR atrophy ,LABORATORY mice ,BLOOD circulation ,NEURODEGENERATION - Abstract
ALS is a fatal neurodegenerative disease that is associated with muscle atrophy, motoneuron degeneration and denervation. Different mechanisms have been proposed to explain the pathogenesis of the disease; in this context, microRNAs have been described as biomarkers and potential pathogenetic factors for ALS. MyomiRs are microRNAs produced by skeletal muscle, and they play an important role in tissue homeostasis; moreover, they can be released in blood circulation in pathological conditions, including ALS. However, the functional role of myomiRs in muscle denervation has not yet been fully clarified. In this study, we analyze the levels of two myomiRs, namely miR-206 and miR-133a, in skeletal muscle and blood samples of denervated mice, and we demonstrate that surgical denervation reduces the expression of both miR-206 and miR-133a, while miR-206 but not miR-133a is upregulated during the re-innervation process. Furthermore, we quantify the levels of miR-206 and miR-133a in serum samples of two ALS mouse models, characterized by different disease velocities, and we demonstrate a different modulation of circulating myomiRs during ALS disease, according to the velocity of disease progression. Moreover, taking into account surgical and pathological denervation, we describe a different response to increasing amounts of circulating miR-206, suggesting a hormetic effect of miR-206 in relation to changes in neuromuscular communication. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
31. Accelerating the Mdx Heart Histo-Pathology through Physical Exercise.
- Author
-
Morroni, Jacopo, Schirone, Leonardo, Vecchio, Daniele, Nicoletti, Carmine, D'Ambrosio, Luca, Valenti, Valentina, Sciarretta, Sebastiano, Lozanoska-Ochser, Biliana, and Bouchè, Marina
- Subjects
MOLECULAR pathology ,MYOCARDIUM ,CAUSES of death ,DUCHENNE muscular dystrophy ,MYOSITIS ,HEART - Abstract
Chronic cardiac muscle inflammation and fibrosis are key features of Duchenne Muscular Dystrophy (DMD). Around 90% of 18-year-old patients already show signs of DMD-related cardiomyopathy, and cardiac failure is rising as the main cause of death among DMD patients. The evaluation of novel therapies for the treatment of dystrophic heart problems depends on the availability of animal models that closely mirror the human pathology. The widely used DMD animal model, the mdx mouse, presents a milder cardiac pathology compared to humans, with a late onset, which precludes large-scale and reliable studies. In this study, we used an exercise protocol to accelerate and worsen the cardiac pathology in mdx mice. The mice were subjected to a 1 h-long running session on a treadmill, at moderate speed, twice a week for 8 weeks. We demonstrate that subjecting young mdx mice (4-week-old) to "endurance" exercise accelerates heart pathology progression, as shown by early fibrosis deposition, increases necrosis and inflammation, and reduces heart function compared to controls. We believe that our exercised mdx model represents an easily reproducible and useful tool to study the molecular and cellular networks involved in dystrophic heart alterations, as well as to evaluate novel therapeutic strategies aimed at ameliorating dystrophic heart pathology. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
32. Phenformin Inhibits Hedgehog-Dependent Tumor Growth through a Complex I-Independent Redox/Corepressor Module.
- Author
-
Di Magno, Laura, Manni, Simona, Di Pastena, Fiorella, Coni, Sonia, Macone, Alberto, Cairoli, Sara, Sambucci, Manolo, Infante, Paola, Moretti, Marta, Petroni, Marialaura, Nicoletti, Carmine, Capalbo, Carlo, De Smaele, Enrico, Di Marcotullio, Lucia, Giannini, Giuseppe, Battistini, Luca, Goffredo, Bianca Maria, Iorio, Egidio, Agostinelli, Enzo, and Maroder, Marella
- Abstract
The antidiabetic drug phenformin displays potent anticancer activity in different tumors, but its mechanism of action remains elusive. Using Shh medulloblastoma as model, we show here that at clinically relevant concentrations, phenformin elicits a significant therapeutic effect through a redox-dependent but complex I-independent mechanism. Phenformin inhibits mitochondrial glycerophosphate dehydrogenase (mGPD), a component of the glycerophosphate shuttle, and causes elevations of intracellular NADH content. Inhibition of mGPD mimics phenformin action and promotes an association between corepressor CtBP2 and Gli1, thereby inhibiting Hh transcriptional output and tumor growth. Because ablation of CtBP2 abrogates the therapeutic effect of phenformin in mice, these data illustrate a biguanide-mediated redox/corepressor interplay, which may represent a relevant target for tumor therapy. • Therapeutic doses of phenformin suppress Hedgehog-dependent tumor growth • Phenformin inhibits mGPD in cancer cells but does not affect complex I activity • Inhibition of tumor mGPD mimics phenformin and increases redox state/NADH content • Elevated NADH promotes Gli1/CtBP2 complex formation and inhibition of tumor growth Di Magno et al. investigate the therapeutic properties of phenformin in Hedgehog-dependent tumors. At clinically relevant doses, phenformin works independent of respiratory complex I through mGPD-mediated increase of the redox state. This promotes CtBP2/Gli1 complex formation and consequent inhibition of Hedgehog transcriptional output and tumor growth. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
33. NAADP-Dependent Ca2+ Signaling Controls Melanoma Progression, Metastatic Dissemination and Neoangiogenesis.
- Author
-
Favia, Annarita, Pafumi, Irene, Desideri, Marianna, Padula, Fabrizio, Montesano, Camilla, Passeri, Daniela, Nicoletti, Carmine, Orlandi, Augusto, Del Bufalo, Donatella, Sergi, Manuel, Ziparo, Elio, Palombi, Fioretta, and Filippini, Antonio
- Published
- 2016
- Full Text
- View/download PDF
34. Correction: Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential.
- Author
-
Oltolina, Francesca, Zamperone, Andrea, Colangelo, Donato, Gregoletto, Luca, Reano, Simone, Pietronave, Stefano, Merlin, Simone, Talmon, Maria, Novelli, Eugenio, Diena, Marco, Nicoletti, Carmine, Musarò, Antonio, Filigheddu, Nicoletta, Follenzi, Antonia, and Prat, Maria
- Subjects
PUBLISHED errata ,PROGENITOR cells ,SPHEROIDAL state ,HEART physiology ,MEDICAL research - Published
- 2015
- Full Text
- View/download PDF
35. Abstract MP10.
- Author
-
SAVOIA, CARMINE, Arrabito, Emanuele, Montezano, Augusto C, Nicoletti, Carmine, Small, Heather Y, Sada, Lidia, Rios, Francisco, Volpe, Massimo, and Touyz, Rhian M
- Abstract
Background: Inhibition of tyrosine kinases receptors such as vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) improves outcomes in patients with cancers. Only VEGFR inhibitors, however, induce severe hypertension whose mechanisms remain unclear. We hypothesized that VEGFR inhibitors may induce early vascular functional and structural alterations, that may precede the development of hypertension.Methods and results: Normotensive SV-129 mice (8 weeks old, 5 for each group) were treated or not with the VEGFR inhibitor Vatalanib (VAT, 100 mg/Kg/day) or the EGFR inhibitor Gefitinib (GEF, 100 mg/Kg/day). Vehicle-treated control mice were also studied. Blood pressure (BP) was measured by tail-cuff method. Endothelium-dependent and -independent relaxations were assessed by concentration-response curves to acetylcholine (1 nM to 100 μM) ± L-NAME (100 μM) and sodium nitroprusside (10 nM to 1 mM) respectively, in mesenteric arteries pre-contracted with norepinephrine (10 μM). Media-to-lumen ratio (M/L, an index of early vascular remodeling), and cross sectional area (CSA) were evaluated on pressurized preparations.After two weeks, BP was similarly preserved in both VAT- and GEF-treated mice as compared to vehicle-treated mice (89.8±1.5 mmHg and 87.2±2.8 mmHg vs 92.2±2.2 mmHg, respectively, NS). Endothelium-dependent relaxation was similarly preserved in vehicle-treated and GEF-treated mice, whereas it was reduced in VAT-treated mice (-17% vs vehicle-treated mice, P<0.05). L-NAME blunted acetylcholine-induced relaxation in all groups except in VAT-treated mice, suggesting an impairment of NO production only in this group. Endothelium-independent relaxation was similar in all groups. Only VAT-treated mice presented increased M/L as compared to vehicle-treated mice (6.3±0.1% vs 5.4±0.1%, P<0.05). M/L resulted similar in GEF-treated and vehicle-treated mice. CSA was similar in all groups.Conclusion: In normotensive mice, only VAT promoted early vascular alterations such as endothelial dysfunction and vascular remodeling in resistance arteries. Those changes in the vasculature are distinctive of hypertension and might precede and sustain the development of the hypertensive disease. [ABSTRACT FROM AUTHOR]
- Published
- 2014
36. Abstract 45.
- Author
-
Savoia, Carmine, Arrabito, Emanuele, Sada, Lidia, Michelini, Serena, Pucci, Lorenzo, Briani, Martina, Nicoletti, Carmine, Candi, Eleonora, Schiffrin, Ernesto L, and Volpe, Massimo
- Abstract
Transglutaminase 2 (TG2) may modulate cell-matrix interactions by inducing cross-linking of proteins. We previously demonstrated that angiotensin II (Ang II) positively regulated TG2 expression in vascular smooth muscle cells from SHR. Here we hypothesized that Ang II induces vascular remodeling in part through TG2.TG2-knockout mice (TG2-K/O, 8 weeks old, 6 for each group) and age-matched wild type (WT) control mice were treated or not with Ang II (400 ng/kg/min) for 14 days. Blood pressure (BP) was measured by tail-cuff method. Endothelium-dependent and -independent relaxation were assessed by concentration-response curves to acetylcholine (1 nM to 100 μM) ± L-NAME (100 μM) and sodium nitroprusside (10 nM to 1 mM) respectively, in mesenteric arteries pre-contracted with norepinephrine (10 μM). Media-to-lumen ratio (M/L) and cross sectional area (CSA) were evaluated on pressurized preparations.BP was higher in TG2-K/O mice compared to WT (120.3±1.3 mmHg vs 88.3±1.9 mmHg, P<0.05), Ang II infusion significantly increased BP only in WT (+28% vs untreated WT, P<0.05), whereas BP was unchanged in TG2-K/O after Ang II infusion. Endothelium-dependent relaxation was similarly preserved in untreated WT, TG2-K/O and Ang II-treated TG2-K/O. Ang II infusion impaired acetylcholine-induced relaxation only in WT (-50% vs untreated WT, P<0.05). L-NAME blunted acetylcholine-induced relaxation in all the groups except in Ang II-treated WT, suggesting an impairment of NO production only in this group. Endothelium-independent relaxation was similar in all groups. TG2-K/O presented reduced M/L as compared to WT (4.8±0.3% vs 6.5±0.2%, P<0.05). Ang II infusion increased M/L only in WT (+13% vs untreated WT, P<0.05). M/L resulted unchanged in TG2-K/O after Ang II infusion. CSA was similar in all groups.In conclusion, despite the higher BP values, TG2-K/O presented improved vascular remodeling compared to WT. Ang II failed to increase M/L and impair endothelial function in TG2-K/O. Hence TG2 may play a role in Ang II-induced vascular structural and functional alterations. [ABSTRACT FROM AUTHOR]
- Published
- 2013
37. Abstract 533.
- Author
-
Savoia, Carmine, Arrabito, Emanuele, Zezza, Luigi, Sada, Lidia, Nicoletti, Carmine, Pucci, Lorenzo, Steckelings, Ulrike M, and Volpe, Massimo
- Abstract
Angiotensin (Ang)-(1-7) through MAS receptor may counteract the Ang II-induced actions. We previously demonstrated that the Ang receptor blocker olmesartan (OLM) improved vascular remodeling in SHR in part through the activation of MAS receptor. Here, we hypothesized that such an effect is independent of Ang II type 2 (AT2) receptor activation. AT2-knockout mice (AT2-K/O, 12 weeks old, n=6 per group) were treated with vehicle (control) or Ang (1-7) (15,5 pmol/kg/min) or Ang II (400 ng/kg/min) ± OLM (10 mg/kg/day) ± the MAS antagonist A-779 (11 pmol/min) for 14 days. BP was measured by tail-cuff method. In isolated mesenteric arteries pre-contracted with norepinephrine (10 μM) endothelium -dependent and -independent relaxation was assessed by dose-response curves to acetylcholine (1 nM to 100 μM) and SNP (10 nM to 1 mM) respectively. Mesenteric arteries media-to-lumen ratio (M/L) and cross sectional area (CSA) were evaluated on pressurized preparations. MAS expression in aorta was evaluated by immunoblotting. Ang II infusion increased BP in AT2-K/O (+20% vs control mice, P<0.05). OLM reduced BP in Ang II-infused mice (104.8±4.4 mmHg vs 121.3±2.8 mmHg, respectively, P<0.05). A-779 had no effect on BP in Ang II-infused mice treated with OLM. Ang (1-7) did not lower BP in AT2-K/O. Endothelium -dependent and -independent relaxations were similar in treated and control mice. M/L was similar in Ang II-infused and control mice. OLM significantly reduced M/L in Ang II-infused AT2-K/O (5.45±0.12 % vs 7.01±0.4%, respectively, -23%, P<0.05). A-779 increased M/L in Ang II-infused AT2-K/O treated with OLM (+18%, P<0.05). Ang (1-7) reduced M/L in AT2-K/O (-21%, P<0.05). CSA was similar in all the groups. MAS expression was similar in Ang II-infused and control mice. MAS expression was increased by OLM in Ang II-infused mice (+108%, P<0.05). A-779 prevented MAS increase in Ang II-infused mice treated with OLM. Ang (1-7) increased MAS expression in AT2-K/O (+81%, P<0.05). In conclusion OLM reduced M/L and improved vascular remodeling in AT2-K/O in part through the increased expression and activation of MAS, independently of BP reduction. Such an effect is indeed independent of AT2 activation, as MAS is functionally active in the vasculature of AT2-K/O. [ABSTRACT FROM AUTHOR]
- Published
- 2012
38. Skeletal Muscle Is a Primary Target of SOD1G93A-Mediated Toxicity.
- Author
-
Dobrowolny, Gabriella, Aucello, Michela, Rizzuto, Emanuele, Beccafico, Sara, Mammucari, Cristina, Boncompagni, Simona, Belia, Silvia, Wannenes, Francesca, Nicoletti, Carmine, Del Prete, Zaccaria, Rosenthal, Nadia, Molinaro, Mario, Protasi, Feliciano, Fanò, Giorgio, Sandri, Marco, and Musarò, Antonio
- Published
- 2009
- Full Text
- View/download PDF
39. Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma.
- Author
-
Infante, Paola, Malfanti, Alessio, Quaglio, Deborah, Balducci, Silvia, De Martin, Sara, Bufalieri, Francesca, Mastrotto, Francesca, Basili, Irene, Garofalo, Mariangela, Lospinoso Severini, Ludovica, Mori, Mattia, Manni, Isabella, Moretti, Marta, Nicoletti, Carmine, Piaggio, Giulia, Caliceti, Paolo, Botta, Bruno, Ghirga, Francesca, Salmaso, Stefano, and Di Marcotullio, Lucia
- Subjects
- *
TUMOR growth , *ANIMAL models in research , *MICELLES , *MEDULLOBLASTOMA , *DRUG stability , *CEREBELLAR tumors , *PROTEIN metabolism , *PROTEINS , *DRUG delivery systems , *BIOLOGICAL models , *RESEARCH , *CELL culture , *COLLOIDS , *BLOOD-brain barrier , *CLINICAL drug trials , *STEROIDS , *ANIMAL experimentation , *RESEARCH methodology , *GLIOMAS , *ANTINEOPLASTIC agents , *MEDICAL cooperation , *EVALUATION research , *BRAIN tumors , *CELLULAR signal transduction , *COMPARATIVE studies , *POLYETHYLENE glycol , *CHROMONES , *CELL lines , *MICE , *DOSAGE forms of drugs , *CHEMICAL inhibitors - Abstract
Aberrant activation of the Hedgehog (Hh) pathway leads to the development of several tumors, including medulloblastoma (MB), the most common pediatric brain malignancy. Hh inhibitors acting on GLI1, the final effector of Hh signaling, offer a valuable opportunity to overcome the pitfalls of the existing therapies to treat Hh-driven cancers. In this study, the toxicity, delivery, biodistribution, and anticancer efficacy of Glabrescione B (GlaB), a selective GLI1 inhibitor, were investigated in preclinical models of Hh-dependent MB. To overcome its poor water solubility, GlaB was formulated with a self-assembling amphiphilic polymer forming micelles, called mPEG5kDa-cholane. mPEG5kDa-cholane/GlaB showed high drug loading and stability, low cytotoxicity, and long permanence in the bloodstream. We found that mPEG5kDa-cholane efficiently enhanced the solubility of GlaB, thus avoiding the use of organic solvents. mPEG5kDa-cholane/GlaB possesses favorable pharmacokinetics and negligible toxicity. Remarkably, GlaB encapsulated in mPEG5kDa-cholane micelles was delivered through the blood-brain barrier and drastically inhibited tumor growth in both allograft and orthotopic models of Hh-dependent MB. Our findings reveal that mPEG5kDa-cholane/GlaB is a good candidate for the treatment of Hh-driven tumors and provide relevant implications for the translation of GlaB into clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
40. Circular RNA ZNF609/CKAP5 mRNA interaction regulates microtubule dynamics and tumorigenicity.
- Author
-
Rossi, Francesca, Beltran, Manuel, Damizia, Michela, Grelloni, Chiara, Colantoni, Alessio, Setti, Adriano, Di Timoteo, Gaia, Dattilo, Dario, Centrón-Broco, Alvaro, Nicoletti, Carmine, Fanciulli, Maurizio, Lavia, Patrizia, and Bozzoni, Irene
- Subjects
- *
CIRCULAR RNA , *MICROTUBULES , *MESSENGER RNA , *NUCLEIC acids , *RNA-binding proteins , *TUMOR growth - Abstract
Circular RNAs (circRNAs) are widely expressed in eukaryotes and are regulated in many biological processes. Although several studies indicate their activity as microRNA (miRNA) and protein sponges, little is known about their ability to directly control mRNA homeostasis. We show that the widely expressed circZNF609 directly interacts with several mRNAs and increases their stability and/or translation by favoring the recruitment of the RNA-binding protein ELAVL1. Particularly, the interaction with CKAP5 mRNA, which interestingly overlaps the back-splicing junction, enhances CKAP5 translation, regulating microtubule function in cancer cells and sustaining cell-cycle progression. Finally, we show that circZNF609 downregulation increases the sensitivity of several cancer cell lines to different microtubule-targeting chemotherapeutic drugs and that locked nucleic acid (LNA) protectors against the pairing region on circZNF609 phenocopy such effects. These data set an example of how the small effects tuned by circZNF609 /CKAP5 mRNA interaction might have a potent output in tumor growth and drug response. [Display omitted] • circZNF609 interacts with CKAP5 , UPF2 , and SRRM1 mRNAs in vivo • circZNF609-mRNA interaction increases ELAVL1 loading on the mRNAs • ELAVL1 loading by circZNF609 regulates stability and translation of its targets • CAKP5 regulation alters MT dynamics, sensitizing cells to chemotherapeutic drugs In this article, Rossi et al. provide an interesting mechanism in which circZNF609-mRNA interaction increases translation, and among them, CKAP5 is a key factor in microtubule dynamics stability. The authors show how the disruption of RNA-RNA interactions is able to alter microtubule dynamics, sensitizing rhabdomyosarcoma cells to chemotherapeutic drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
41. p66ShcA and Oxidative Stress Modulate Myogenic Differentiation and Skeletal Muscle Regeneration after Hind Limb lschemia.
- Author
-
Zaccagnini, Germana, Martelli, Fabio, Magenta, Alessandra, Cencioni, Chiara, Fasanaro, Pasquale, Nicoletti, Carmine, Biglioli, Paolo, Pelicci, Pier Giuseppe, and Capogrossi, Maurizio C.
- Subjects
- *
OXIDATIVE stress , *OXIDATION-reduction reaction , *MYOBLASTS , *CELL differentiation , *MUSCLE regeneration , *ISCHEMIA , *BIOCHEMISTRY - Abstract
Oxidative stress plays a pivotal role in ischemic injury, and p66ShcAko mice exhibit both lower oxidative stress and decreased tissue damage following hind limb ischemia. Thus, it was investigated whether tissue regeneration following acute hind limb ischemia was altered in p66ShcAko mice. Upon femoral artery dissection, muscle regeneration started earlier and was completed faster than in wild-type (WT) control. Moreover, faster regeneration was associated with decreased oxidative stress. Unlike ischemia, cardiotoxin injury induced similar skeletal muscle damage in both genotypes. However, p66ShcAko mice regenerated faster, in agreement with the regenerative advantage upon ischemia. Since no difference between p66ShcAwt and knock-out (ko) mice was found in blood perfusion recovery after ischemia, satellite cells (SCs), a resident population of myogenic progenitors, were examined. Similar SCs numbers were present in WT and ko mice. However, in vitro cultured p66ShcAko SCs displayed lower oxidative stress levels and higher proliferation rate and differentiated faster than WT, Furthermore, when exposed to sublethal H2O2 doses, p6ShcAko SCs were resistant to H2O2- induced inhibition of differentiation. Finally, myogenic conversion induced by MyoD overexpression was more efficient in p66ShcAko fibroblasts compared with WI. The present work demonstrates that oxidative stress and p66ShcA play a crucial role in the regenerative pathways activated by acute ischemia. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.